Can-Fite BioPharma Rings The Opening Bell at NYSE

Can-Fite Biopharma Ltd - $CANF |

On Dec. 5, Can-Fite BioPharma (CANF)  celebrated rang the Opening Bell at the New York Stock Exchange to celebrate the Petach Tikva, Israel-based company's recent listing on the NYSE MKT. CEO Dr. Pnina Fishman was joined by key members of the company's management team and their guests for the momentous ceremony. Can-Fite is a biotechnology company with a pipeline of proprietary small molecule drugs that address inflammatory and cancer diseases. Be sure to read's interview with Dr. Fishman here to learn more about Can-Fite's strategic focus and goals going forward.


DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to:


Symbol Name Price Change % Volume
BMQCF Bank of Montreal Non Cumulative 5-Year Rate Reset n/a n/a n/a 0
CANF Can-Fite Biopharma Ltd Sponsored ADR (Israel) 2.42 0.01 0.41 15,809


Emerging Growth

Gold Reach Resources Ltd.

Gold Reach Resources Ltd is engaged in the acquisition, exploration and development of mineral properties in British Columbia.

Private Markets


A peer-to-Peer authentic photo marketplace disrupting the $10B commercial photography industry.


Airbnb is a community marketplace for people to list, discover, and book unique accommodations around the world — online or from a mobile phone. Whether an apartment for a night,…